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Venoms contain active substances with highly speciﬁc physiological effects and are
increasingly being used as sources of novel diagnostic, research and treatment tools for
human disease. Experimental characterisation of individual toxin activities is a severe rate-
limiting step in the discovery process, and in-silico tools which allow function to be pre-
dicted from sequence information are essential. Toxins are typically members of large
multifunctional families of structurally similar proteins that can have different biological
activities, and minor sequence divergence can have signiﬁcant consequences. Thus,
existing predictive tools tend to have low accuracy. We investigated a classiﬁcation model
based on physico-chemical attributes that can easily be calculated from amino-acid se-
quences, using over 250 (mostly novel) viperid phospholipase A2 toxins. We also clustered
proteins by sequence proﬁles, and carried out in-vitro tests for four major activities on a
selection of isolated novel toxins, or crude venoms known to contain them. The majority of
detected activities were consistent with predictions, in contrast to poor performance of a
number of tested existing predictive methods. Our results provide a framework for com-
parison of active sites among different functional sub-groups of toxins that will allow a
more targeted approach for identiﬁcation of potential drug leads in the future.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license. 1. Introduction
Animal toxins often form functionally diverse families,
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er Ltd. Open access under CC BYscaffolds yet achieving a diverse range of physiological ef-
fects through interaction with a multitude of molecular
targets. They offer a virtually unlimited pool of bioactive
compounds with therapeutic and pharmacological poten-
tial, a fact which is attracting increasing interest in aca-
demic, industrial and medical arenas (King, 2011). Pre-
screening of newly identiﬁed compounds with in-silico
techniques to identify functional hypotheses for subse-
quent experimental testing is highly desirable but limited
by current levels of accuracy of many existing bioinfor-
matics methods (Clark and Radivojac, 2010; Koonin, 2000).
Even computationally quite complex methods may have
prediction accuracies of less than 50% when applied to
functionally diverse protein families (Engelhardt et al.,
2011). An excellent example is provided by toxins based license. 
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component of reptile venoms, which hydrolyse phospho-
lipids to release lysophospholipids and fatty acids (Kini,
1997). They also have toxic activities (including pre- and,
more rarely, post-synaptic neurotoxicity, myotoxicity, car-
diotoxicity, anticoagulant and haemolytic activity) that are
independent of the catalytic activity of the enzyme and
many PLA2 toxins are in fact phospholipase homologues, in
which mutational changes to the active site have abolished
the phospholipase activity. Toxicity can occur through
highly speciﬁc direct binding to membrane-bound, intra-
cellular receptors or coagulation factors present in
mammalian blood, or through interactions dependant on
the three-dimensional structure of the folded protein,
either in monomeric or dimeric form (Chioato and Ward,
2003). Group II PLA2s (most similar to non-toxic PLA2s in
mammalian synovial ﬂuid and testes [Doley et al., 2009])
are especially signiﬁcant in viperid snakes, where they may
make up to 70% of the protein content of crude venom.
They are frequently present as multiple isoforms in the
venom of single species (Calvete et al., 2011), and even a
single individual (Danse et al., 1997; Ogawa et al., 1992),
and have been shown to be the most variable of all major
protein families in the venom, both intra- and inter-
speciﬁcally (Sanz et al., 2006).
The proliferation of functional activity appears to be
dependent on the mutation of highly speciﬁc surface resi-
dues, which are hypothesised to change the speciﬁc target
of the protein and thus confer a new activity (Doley et al.,
2009). Predictions have been made about the position of
pharmacological sites following functional studies on iso-
enzymes (Kini, 2006; Kini and Iwanaga, 1986a,b), while
chemical modiﬁcation, site-directed mutagenic mapping,
use of monoclonal and polyclonal antibodies and analysis
of inhibitor interactions have identiﬁed particular residues
or segments of the PLA2 molecules that are involved in
different activities (Doley et al., 2009). A more recent and
promising line of research uses biomimetic synthetic pep-
tides to narrow down potential pharmacological sites
(Lomonte et al., 2010). However, these studies often
disagree and have generally failed to allow prediction of
activity in other isoforms of unknown activity. In recent
years, the discovery rate of new toxins has increased
exponentially, as venom gland transcriptomic (EST) studies
have resulted in the description of hundreds of new toxins
(Boldrini-França et al., 2009; Durban et al., 2011; Junqueira-
de-Azevedo and Ho, 2002; Kashima et al., 2004; Wagstaff
and Harrison, 2006; Zhang et al., 2006). More recent
application of next-generation sequencing technology
(Chatrath et al., 2011; Jiang et al., 2011; Rodrigues et al.,
2012) to transcriptomics will further accelerate this pro-
cess, as will the increasing ability to directly access the
genome through extended read length and targeted
sequencing (Glenn, 2011). However, current methods for
studying pharmacological activity are generally labour-
intensive and the functional characterisation of these new
toxins is unlikely to keep pace (not unique to toxins, as the
majority of protein sequences in databases lack functional
annotation). Computer-generated annotations have been
shown to be highly inaccurate (Schnoes et al., 2009) mainly
as a result of over-prediction (i.e., annotation to functionsthat are more speciﬁc than the available evidence supports,
sometimes naively based on homology to primary struc-
tures). This is likely to be the case for most animal toxins,
which often retain the ancestral non-toxic structural scaf-
fold, while evolving diverse potent and highly speciﬁc toxic
activities. In some cases, the substitution of a single amino
acid is enough to change the selectivity for another target
(Ohno et al., 1998). In the case of PLA2 toxins, the ancestral
phospholipase activity may be readily predicted while
failing to predict the main biological activity of the protein
in question. Thus, predicting the function of snake venom
proteins based on a common scaffold presents a challenge
to bioinformaticians interested in the analysis of protein
sequence–function relationships in general. Solving this
problem will have a number of beneﬁcial outcomes as
many of the activities of these proteins are of great utility as
research tools and potential drugs (Koh et al., 2006),
especially in neurological (Sun et al., 2004), anti-cancer
(Bazaa et al., 2010; Lomonte et al., 2010), anti-viral
(Fenard et al., 1999; Meenakshisundaram et al., 2009) and
anti-inﬂammatory (Coulthard et al., 2011) research.
In this paper, we report a model-based analysis of the
largest dataset of PLA2 Group II toxins to date, comprising
251 protein sequences. Of these, 73 are novel sequences
derived from a genome-based survey of PLA2 genes in
pitvipers (Viperidae: Crotalinae), including 16 species for
which no PLA2 sequences exist in databases. Most of the
newly investigated species belong to the Asian Trimeresurus
radiation (Malhotra and Thorpe, 2004), which have been
relatively understudied by toxinologists (Gowda et al.,
2006; Soogarun et al., 2008; Tan and Tan, 1989; Tan et al.,
1989; Wang et al., 2005). We used two methods with
different conceptual bases. The ﬁrst was based on ordina-
tion of proteins with experimentally characterised func-
tions, using biologically meaningful features derived from
their physico-chemical characteristics in a discriminant
function analysis (DFA). The second was based on primary
sequence structure, measured by sequence proﬁles. DFA
correctly classiﬁed between 62 and 86% of toxins with
knownphysiological functions, with a goodmatch between
structural similarity and predicted function in the proﬁle-
based clustering method. In marked contrast, a number of
alternative protein prediction methods failed to correctly
identify more than the basic enzymatic function of the PLA2
scaffold. In-vitro tests for four major activities showed that
the activity of the majority was consistent with predicted
functions. An advantage of the methods applied here is that
they do not require specially-written software as all
methods are already readily available in the public domain.
If required, a bioinformatics pipeline to scale up these an-
alyses to take advantage of high-throughput datasets from
large-scale drug discovery programs could easily be
constructed.
2. Experimental
2.1. Samples, cloning of PLA2 genes and quality checking
Samples were collected between 1992 and 2002 as part
of a systematic study on Asian pitvipers (Malhotra and
Thorpe, 2004) and were in the form of blood samples,
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ampliﬁed PLA2 genes directly from genomic extracts using
conserved primers located in the untranslated regions of
the PLA2 genes, cloned individual PCR products, and
sequenced multiple positive clones using the primers and
procedures described previously (Dawson et al., 2010).
Similar sequences from individual samples were grouped
for detection of PCR errors and construction of consensus
sequences, based on a statistically robust method of
determining the probability of obtaining PCR artefacts
(Dawson et al., 2010). However, we modiﬁed the accep-
tance criterion such that the minimum number of differ-
ences separating two sequences that had conﬁrmed
translation products in the venom (detected by proteomic
analysis) was used set the acceptance threshold, if this was
less than the threshold value determined by the cumulative
binomial distribution. We applied a number of methods for
the detection of recombinant sequences in an alignment:
RDP, Geneconv, Chimaera, 3SEQ (all implemented in RDP3
[Martin et al., 2005]). Those showing clear evidence of
recombination within sequences derived from single in-
dividuals were removed as likely PCR artefacts. Remaining
sequences were aligned by eye into exons and introns using
known splice sites in a reference PLA2 sequence from Pro-
tobothrops ﬂavoviridis (D13383). The putative protein-
coding sequence was assembled and translated using
EXPASY tools (web.expasy.org). The UniProt database and
literature sources were searched for additional non-
redundant crotaline PLA2 protein sequences and resulting
database aligned using MUSCLE (Edgar, 2004), imple-
mented within Jalview (Waterhouse et al., 2009).
2.2. Proteomics: analysis of expressed PLA2 toxins
Venom samples were obtained from a single milking of
individual snakes, dried, and stored at 4 C. Our goal was
a) to characterise the expression proﬁle of PLA2 toxins in
the crude venom, and b) to isolate several PLA2s for activity
testing (which was limited by the amount of crude venom
available). Crude venom samples from 132 specimens of 29
species of Crotalinae were analysed by MALDI–TOF (ma-
trix-assisted laser-desorption ionisation–time-of-ﬂight)
MS as described previously (Creer et al., 2003). Some later
analyses were carried out using an Ultraﬂex TOF/TOF
(Bruker Daltonics, Germany) with only minor modiﬁca-
tions of the protocol. Calibrants used in the MALDI–TOF
analyses were bovine insulin, ubiquitin I, cytochrome C,
and myoglobin. Most samples were analysed at least twice,
with some samples being analysed in each different set of
analyses, which were carried out over a number of years. To
check the reproducibility of the venom proﬁle within in-
dividuals, we also analysed venom samples from captive
individuals that had been collected monthly over the
course of one year. A limited number of samples were also
analysed using LC–ES (liquid chromatography–electrospray
ionisation tandem) MS, to check the accuracy and repro-
ducibility of results, as described previously (Creer et al.,
2003). The mass range between 13 and 14.5 kDa was ana-
lysed using Data Explorer Version 3.5.0.0 (PerSeptive Bio-
systems). ‘Major’ peaks were deﬁned as those with greater
than 30% maximum intensity for MALDI–TOF analysis,while for LC–MS they corresponded to compounds exhib-
iting a UV absorption (214 nm) superior to 15% of the
relative maximum intensity for LC–MS. In case of co-
eluting proteins, the MS spectrum was taken into account
and only the major representatives are considered as
‘major’ forms. ‘Secondary’ peaks were those with less than
30% maximum intensity for MALDI–TOF analysis, or those
which correspond to compounds exhibiting a UV absorp-
tion (214 nm) inferior to 15% of the relative maximum in-
tensity for LC–MS. Observed masses were subsequently
grouped together if their masses were within the limits of
the accuracy of the method used to determine them (i.e.,
within 10Da for two masses determined using MALDI–TOF,
2Da for those determined by LC–ES–MS, or 6Da for a mass
determined by MALDI–TOF compared to one determined
by LC–ES–MS). This procedure is conservative in that some
PLA2s withmasses within the limits given abovemay result
from different underlying sequences, but it minimises the
chances of false discovery. TagIdent (EXPASY) was used to
search UniprotKB/Swissprot for matches with individual
sequenced isoforms.
Isoform content is particularly diverse and variable in
the Chinese bamboo viper Viridovipera stejnegeri on the
island of Taiwan (Creer et al., 2003). The distribution of high
molecular weight versus low molecular weight isoforms is
not random and appears to be correlated with diet. On the
basis of the MALDI–TOF proﬁles, we chose one specimen
(T61) from Green island, Taiwan (5.4 mg of dry crude
venom), and two specimens (T221 and T224) with a similar
venom proﬁle from Fujian province, China (4.7 mg com-
bined weight of dried venom), in which high and low
molecular weight PLA2s respectively formed the major
components of the venom. The puriﬁcation of the PLA2s
was carried out using Reverse-phase HPLC on 1mg of crude
venom. All the fractions were manually collected and a
MALDI–TOF–MS analysis was performed in order to
conﬁrm the ﬁnal mass of each fraction. Finally, the quantity
and purity of eachmanually collected fractionwas assessed
by size exclusion chromatography.
2.3. Biological activities of venoms
Haemorrhagic activity was assessed by exposing blood
vessels serving unhatched chick embryos to ﬁlter paper
discs (2 mm diameter) loaded with ﬁxed concentrations of
venom samples in 0.9% w/v NaCl (44), using Bothrops jar-
araca venom as a positive control and 0.9% w/v NaCl alone
as a negative control (Sells et al., 1998). Haemorrhagic ac-
tivity was measured as the time taken for a haemorrhagic
corona to appear around the disc, and the area of the
corona after continuous contact with the disc for 2hr.
Myotoxic and neurotoxic activity were assessed by incu-
bating mouse soleus muscles at room temperature in
oxygenated Liley’s ﬂuid for three hours in the presence of
samples of venom or venom fractions at a ﬁxed concen-
tration of 10 mgml1. At the end of the period of incubation,
muscles were lightly ﬁxed, cryoprotected, frozen in liquid
N2 and sectioned at 6 mm (TS) and 10 mm (LS). For the
assessment of myotoxicity, sections were stained with H &
E and evidence of frank necrosis, hyper-contraction, and
oedematous separation of necrotic muscle ﬁbres (Harris
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sections were labelled with a primary antibody for syn-
aptophysin (a protein speciﬁc to synaptic vesicles) and a
primary antibody for neuroﬁlament (a protein speciﬁc to
axons) and then to a secondary antibody conjugated to a
ﬂuorescent tag. Each section was counter-labelled with
alpha-bungarotoxin conjugated to a ﬂuorescent tag to
identify the ACh receptors at the neuromuscular junction.
Neurotoxicity was assessed by the absence of labelling for
synaptophysin at the neuromuscular junction, or by
abnormal labelling of neuroﬁlament (Dixon and Harris,
1999; Prasarnpun et al., 2005). At least two muscles were
used for each compound.
2.4. Discriminant analysis of protein physico-chemical
properties
We used SMS (http://www.bioinformatics.org/sms2/
protein_gravy.html) and Protparam (EXPASY) to calculate
a number of sequence-based features including pI (iso-
electric point), MW (theoretical average molecular weight,
without any correction made for disulphide bridges), net
charge, GRAVY (GRand AVerage of hYdropathy [Kyte and
Doolittle, 1982]), aliphatic index (a measure of the ther-
mostability of globular proteins), instability index and
amino acid composition (%). The 20 amino-acid composi-
tion values were converted into compositional similarity
scores using principal component analysis, retaining the
maximum number of functions for which the chi-square
test of Wilks’ lambda was signiﬁcant at P < 0.05. We ana-
lysed these physico-chemical variables of the pitviper
venom PLA2s by DFA in SPSS v.14, using functional activities
as groups and individual PLA2 toxins as cases. Data on
functional activity were primarily gathered from UniProt.
However, it has previously been noted that many database
protein entries are not annotated with function (Tan et al.,
2003), there are no actively maintained databases specif-
ically for snake venom toxins, and the only current data-
base on animal toxins has limited functionality (Jungo et al.,
2012). Therefore, we also carried out searches of the pri-
mary literature using GoPubMed (www.gopubmed.org).
Reported functional activities of PLA2s are very varied; 15
are listed by Kini (1997) while Doley et al. (2009), mention
at least 12 distinct activities. For simplicity, we reduced the
number of activities to the six most commonly reported,
i.e., neurotoxic, myotoxic, antiplatelet, anticoagulant,
oedematous, and hypotensive. Variables were entered
together and posterior probabilities of group membership
(including for the ungrouped proteins, which did not take
part in the discrimination, but whose position relative to
the calculated axes was also calculated) were saved.
2.5. Proﬁle-based methods
A sequence proﬁle represents the information con-
tained in a multiple sequence alignment as a table of
position-speciﬁc symbol comparison values and gap pen-
alties. The proﬁle-based neighbour-joining (PNJ) method is
a means of obtaining more resolution in a large tree by
successively collapsing clusters supported above a certain
user-determined value into a summary proﬁle. It is claimedto be as accurate as Bayesian methods, but much more
computationally efﬁcient (Müller et al., 2004). We used
ProfDistS v0.9.8 (Wolf et al., 2008), with general time-
reversible distances based on the VTML model, which
models protein evolution as a Markov process (Müller and
Vingron, 2000). Proﬁles were built for clusters with either
sequence identity above 97% or bootstrap values (from 500
bootstraps of the initial NJ tree) of greater than 70% in an
iterative process (Merget andWolf, 2010). The resulting PNJ
tree was rooted and annotated in Dendroscope 3 (Huson
and Scornavacca, 2012). It is important to note that the
resulting tree reﬂects the degree of structural similarity
among amino-acid sequences, and will not necessarily
reﬂect evolutionary relationships among the sequences
(i.e., it is not a gene tree) since the non-coding parts of the
gene may be quite divergent.
2.6. Comparison with other prediction methods
A multitude of computational tools are available for the
prediction of molecular function based on de novo protein
sequences (Punta and Ofran, 2008). The more powerful
programs combine several approaches. One of these, Prot-
fun (available at http://www.cbs.dtu.dk/services/ProtFun-
2.2/), integrates 14 different sequence-based prediction
methods, using attributes such as number of negative and
positive residues and predicted transmembrane helices,
into ﬁnal predictions of the cellular role, enzyme class (if
any), and selected Gene Ontology (GO) categories of the
submitted sequence (Juhl-Jensen et al., 2003). As there is a
limit of 50 sequences on the server, we assembled a ﬁle
containing 49 sequences of proteins, in which experimen-
tally determined functions matched the predictions of the
DFA (PP > 0.8), plus four additional protein sequences with
no experimentally determined function, but which the DFA
predicted to have a hypotensive or oedematous function
with PP > 0.9. We also used another multiple-approach
protein function prediction engine, EFICAz2.5 available at
http://cssb.biology.gatech.edu/skolnick/webservice/
EFICAz2/index.html. This combines predictions from six
different methods developed and optimised to achieve
high prediction accuracy (Narendra and Skolnick, 2012).
However, the server takes only one sequence at a time,
which limits its utility for large-scale protein discovery
projects. Finally, we tested a method employing a similar
approach to ours in that it uses features derived from pri-
mary sequence such as such as normalised Van der Waals
volume, polarity, charge and surface tension. However,
rather than employing these measures directly, they are
converted into three descriptors which reﬂect the global
composition of each of these properties, and these de-
scriptors are then combined into a feature vector, achieving
accuracy in the range 69.1–99.6% (Cai et al., 2003). For the
enzyme class to which the PLA2s belong (EC3.1), a sensi-
tivity of 71.1% and speciﬁcity of 90.6% is claimed. The server
is available at http://jing.cz3.nus.edu.sg/cgi-bin/svmprot.
cgi.
To our knowledge, only a handful of other studies have
attempted to develop bioinformatic tools speciﬁcally for
prediction of the biological properties of snake venom PLA2
proteins. Two of these focused on neurotoxins only (Saha
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ing between myotoxins and neurotoxins (Pazzini et al.,
2005), and another (Chioato and Ward, 2003) was
applied to myotoxins, neurotoxins and anticoagulants.
Although these were mostly accompanied by publicly-
available programs, only one of these is currently acces-
sible. Consequently, we could only test the predictive
power of NTXpred (Saha and Raghava, 2007) available at
www.imtech.res.in/raghava/ntxpred/. According to the
authors, this server allows users to predict neurotoxins
from non-toxins with 97.72% accuracy, allows the classiﬁ-
cation of neurotoxic proteins by their organismal source
with 92.10% overall accuracy, and by function (e.g., ion
channel blockers, acetylcholine receptor blockers etc.) with
95.11% overall accuracy. Furthermore, it claims that users
can sub-classify ion-channel inhibitors by type with 75%
overall accuracy. The interface is simple and limited to the
input of one sequence at a time. Consequently, we selected
two to three toxins of each functional type to test, from the
ﬁle described above.
3. Results
3.1. Description of novel PLA2 proteins
Full-length sequences of PLA2 genes ranging in length
between 1832 and 2001 bp were obtained from 24 in-
dividuals of 20 nominal species. The minimum difference
required for acceptance of variants as non-PCR artefacts
was set at 4 bp. After several putative artefactual
recombinants were eliminated from the dataset, it con-
sisted of 94 gene sequences. Putative proteins inferred from
the coding regions bore hallmarks of expressed genes,
including the presence of a TATA-like box and several pu-
tative regulatory elements (Gubensek and Kordis, 1997)
immediately preceding it at the 50 end, and the polyA tail at
the 30 end. Several genes detected encoded previously
described toxins from protein or cDNA studies. For
example, B464_LT6 (UniProtKB: tbc) from Protobothrops
(previously Zhaoermia) mangshanensis encodes a protein
with 99% similarity to zhaoermiatoxin (Mebs et al., 2006),
while A54_LT6 from Calloselasma rhodostoma (UniProtKB:
tbc), differs by only a single amino acid near the C-terminus
from CRV-W6D49 (Tsai et al., 2000). Several distinct genes
(as deﬁned above) recovered from the same individual (e.g.,
B33) or individuals from different populations of the same
species (e.g., two Cryptelytrops specimens B117 and B5,
from South Vietnam and West Java respectively) were
found to encode identical proteins. Additionally, several
genes encoded toxins with inferred molecular weights that
matched the MWof proteins detected byMS analysis of the
crude venom obtained from the same, or related, individ-
ual. Finally, 10 genes appeared to encode pseudogenes
(with either unusually short or long inferred protein se-
quences according to the position of the ﬁrst TAA or TAG
codon). Accession numbers, origins, inferred MW and pI,
sequence features and matches found for the novel se-
quences in venom MS proﬁles are shown in Table S1 of the
Supplementary Information.
Putatively translated proteins (n ¼ 73) varied from 119
to 124 amino acids, within the range of previouslydescribed Group II PLA2s (Kini, 1997) and (with the
exception of ﬁve proteins which had six disulphide
bridges), had the usual seven disulphide bridges. The
inferred proteins fell into a number of classes previously
described, based on the residue present at the 48th position
in the amino-acid sequence. Somewhat confusingly, this
position is designated 49 in the numbering system pro-
posed by Renetseder et al. (1985) based on a comparison
with bovine pancreatic PLA2, in which residue 15 has been
deleted in all svPLA2s. The commonest variant was D49
(n ¼ 57), in which the catalytic site is preserved, with a
minority (n ¼ 6) being K49 (phospholipase homologues).
There were also a number of variants at this position (N:6,
H:1, R:2, T:1) that have only rarely been previously reported
(Chijiwa et al., 2006; Tsai et al., 2003; Wei et al., 2006). The
residue at the sixth position of the amino-acid sequence is
also signiﬁcant in determining some important properties
of the protein (Mebs et al., 2006). The largest proportion of
sequences fell into the E6 category (n ¼ 49, mostly of the
D49 type, but also including N, K, R and H49 proteins). Most
of the E6 proteins are acidic (4 > pI > 5.5), but a few are
neutral or weakly basic (pI ¼ 6.4–8.95), although all are
within the range previously reported for E6 proteins. For
additional variants at the 6th position (A, G, R, T, W), see
Table S1.
3.2. Proteomic study of PLA2 expression
Oxidation products (clearly distinguishable as double
peaks differing by 16 Da) were frequently present. Among
the 10 samples that had been fractionated, isolated iso-
forms were found to be up to 20% oxidised. These often
formed minor peaks in the LC–ES–MS and were generally
absent in the MALDI–TOF spectra. From the 132 venoms
examined, at least 83 masses representing putative unique
PLA2 isoforms were identiﬁed between 13,193 and
14,916 Da. Between two (Popeia sabahi, A202, Ovophis
makazayazaya, A87) and 10 (Viridovipera gumprechti, B475)
isoforms were found in the 24 samples with both LC–ES
and MALDI–TOF–MS data. Between 25 and 100% (mean
70.45%) of isoforms in individual venoms were detected
using both methods. Most of the masses which did not
occur in both types of spectra were present as minor peaks
in LC–ES–MS. About 70% of isoforms detected were scored
as a major or minor peak consistently in both analyses.
There was no signiﬁcant difference between repeat spectra
of the same venom sample, or from venom samples taken
at different times from the same individual, although the
relative intensity of different peaks and presence of
absence of minor peaks were not consistent in some cases.
Out of the 73 proteins inferred from the genomic sequences
obtained in this study, 62 (c. 85%) had a putative match in
the expressed venom (Table S1). However, several isoforms
with different amino-acid sequences have inferred masses
that are within 2 Da of each other, which are difﬁcult to
discriminate using proteomic methods (Table S1), even the
more accurate LC–ES–MS. Only 23 (32%) inferred PLA2
proteins were matched to masses in the venom proﬁle of
the same individual fromwhich the genome sequence had
been obtained, suggesting that selective expression may
account for a large proportion of among-individual
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incomplete sampling of the PLA2 gene content of the ge-
nomes investigated.
3.3. Biological activities
The application of saline-loaded discs of ﬁlter paper
caused no haemorrhage and no obvious disturbance to the
chick embryos. Discs loaded with B. jararaca venom
exhibited concentration-dependant haemorrhage, with a
threshold concentration of 1.0 mg in 2.0 ml. The area of
haemorrhagic corona increased with venom concentration
and was maximal at a concentration of 3 mg in 2.0 ml, while
the time taken for the corona to form fell. From these data,
a ranking of haemorrhagic potential was calculated
(Table 1). Of the venom samples tested, B135, T221, T61, T61
(fraction 16), T61 (fraction 20) had no detectable haemor-
rhagic activity. Two samples (B475 and B22) were highly
active, as active as the standard haemorrhagic venom (B.
jararaca). Venom samples from B208, B33, B67 and B5 were
moderately active (compared to B. jararaca), while those
from B8, B469 and A229 were of low haemorrhagic activity.
Myotoxic activity was rare and usually mild. Only T224,
T221 and T61 (fraction 20) were clearly myotoxic although
B526 and T208 were mildly myotoxic. Oedema was com-
mon, but non-speciﬁc (Table 1). Clear evidence of neuro-
toxicity was seen only with T61 (fraction 20) (Table 1,
Fig. S1).
3.4. Prediction of function: discriminant analysis
The total dataset contained 253 non-redundant protein
sequences (Fig. 1). The alignment is available in the Dryad
data depository (doi:10.5061/dryad.16pg7). The ﬁrst fourTable 1
Biological activities of several characterised crude venoms and three isolated iso
Venom ID Species Time to
corona
Rank Size of
corona
(mm2)
Rank R
(
a
þve control Bothrops jararaca 26.5 5 17 2 2
ve control – n/a n/a n/a n/a n
Notexin Notechis scutatus n/a n/a n/a n/a n
b Bungarotoxin Bungarus spp. n/a n/a n/a n/a n
A229 Cryptelytrops
albolabris
66 10 5.5 9 1
T208 Viridovipera
stejnegeri
24 4 8 7 4
B475 V. gumprechti 20 2 19 1 1
B8 C. insularis 44 9 16 3 8
B22 C. albolabris 17 1 8.6 6 2
B526 “Ovophis”
okinavensis
50 11 3.2 11 1
B5 C. albolabris 30 7 11 4 4
B33 Parias hageni 27 6 8.8 5 4
B67 C. cardamomensis 21 3 7.7 8 4
B469 Popeia sabahi 43 8 5.3 10 9
B135 Tropidolaemus
wagleri
Not haemorrhagic 12¼ 1
T221 (crude) V. stejnegeri Not haemorrhagic 12¼ 1
T221 (Q6H3D7))
T61 (crude)
V. stejnegeri Not haemorrhagic 12¼ 1
Not haemorrhagic 12¼ 1
T61/16 (Q6H3D4) Not haemorrhagic 12¼ 1
T61/20 (D31778) Not haemorrhagic 12¼ 1factors describing amino acid composition were retained.
These principal components, referred to as PC1-4(comp)
hereafter, summarised 16.7, 14.0, 10.1, and 9.5% of varia-
tion respectively. Ninety-ﬁve proteins had known functions
that could be assigned to one of six major functions.
However, anticoagulant and antiplatelet functions were
subsequently combined into a “haemotoxic” category after
preliminary analyses showed that no physico-chemical
property or PC(comp) could distinguish between these
groups (Tamhane’s post-hoc test). Final sample sizes were:
Myotoxic: 30; Haemotoxic: 19; Neurotoxic: 26; Hypoten-
sive: 7; Oedematous: 15. Neurotoxic PLA2s frequently also
show myotoxicity (Montecucco et al., 2008), but were
classed as neurotoxic rather than myotoxic for the purpose
of this analysis. Robust tests (Brown-Forsythe) for the
equality of means showed all variables apart from
PC2(comp) showed signiﬁcant differences among groups.
The four resulting discriminant functions (Table 2) con-
tained 69.1, 13.5, 11.1, and 6.3% of variation respectively.
Another 158 proteins which had no known function were
plotted on the resulting axes (Fig. 2) and colour-coded by
their posterior probabilities of belonging to one of the
functional groups (Table S2). All groups, except for hae-
motoxic and hypotensive proteins, were successfully
discriminated on two axes (Fig. 2A). DF1 largely reﬂects the
difference in pI, with haemotoxic/hypotensive proteins
being acidic, myotoxic, neurotoxic and most oedematous
proteins being basic. However, notably some oedematous
proteins can be distinguished frommyotoxic ones by being
more neutrally charged at pH7. DF2 (Table 2, Fig. 2A) largely
distinguishes a smaller group of oedematous proteins on
the basis of PC3(comp), with oedematous toxins having
lower amounts of phenylalanine, arginine and tyrosine, and
higher amounts of methionine and valine. DF3 (not shown)forms.
ank overall
haemorrhagic
ctivity)
Oedema Myotoxicity AchR S1
physin
%
innervated
¼ n/a n/a n/a n/a n/a
/a Slight X 43 40 93
/a O O n/a n/a n/a
/a n/a n/a 62 16 26
0 X X 28 28 100
¼ O O 28 28 100
O X 72 66 92
X X 52 48 92
¼ X X 15 12 80
1 X Slight 20 18 90
¼ X X 33 30 91
¼ X X 42 38 90
¼ X X – – –
X X 42 40 95
2¼ X X 75 62 83
2¼ O O 54 48 89
2¼ – – – – –
2¼ – – 22 20 91
2¼ X X 13 13 100
2¼ O O 20 0 0
Fig. 1. Sequence logo constructed from the 251 PLA2 sequences included in this study, showing conserved and variable regions. Standard amino-acid single-letter
codes are used, and the size of the letter indicates the degree of conservation of the sequence at that position. In order to preserve the standard PLA2 numbering
system (Renetseder et al., 1985), gaps have been introduced even though no svPLA2 has a residue present at that position, and a few extra inserted residues found
in a minority of svPLA2s (fewer than two) have been deleted. Major three-dimensional structural features are shown as blue boxes and residues participating in
the catalytic activity of the enzyme have been indicated using stars.
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further distinguishes myotoxins proteins from oedematous
proteins and neurotoxins, with myotoxins displaying a
lower net charge for a given pI than the other types. Finally,
hypotensive PLA2s are distinguished from haemotoxins on
the fourth axis (Fig. 2B), by a lower pI, a higher proportion
of leucine and lycine and a lower amount of alanine,
cysteine, glutamic acod and glutamine, being lessTable 2
Standardised eigenvector coefﬁcients for canonical discriminant functions
on viperid PLA2 composition and physico-chemical properties. The co-
efﬁcients shown in bold contribute the most to the respective discrimi-
nant function (DF).
Function variable DF1 DF2 DF3 DF4
GRAVY 0.345 0.504 0.542 L0.784
Instability index 0.095 0.047 0.320 0.409
Aliphatic index 0.265 0.743 0.205 0.882
Amp score 0.164 0.018 0.655 0.188
Net charge L0.851 0.598 2.184 L0.742
NO. A.A. 0.010 0.008 0.467 0.591
pI 1.789 0.643 L1.634 0.920
MW 0.042 0.169 0.784 0.166
PC1(comp) 0.053 0.497 0.235 0.661
PC2(comp) 0.068 0.506 0.295 0.908
PC3(comp) 0.122 0.974 0.087 0.281
PC4(comp) 0.340 0.136 0.140 0.494thermostable and more hydrophilic. Of original grouped
toxins, 72.6% were correctly classiﬁed while cross-
validation correctly classiﬁed 60% of toxins. Of the 27
known myotoxic proteins, 21 (78%) were correctly pre-
dicted. The prediction accuracy of known hypotensive
proteins is 86% (6 out of 7), while neurotoxic and oedem-
atous proteins were both correctly predicted in 62% of
cases. Haemotoxic proteins were correctly predicted in 74%
of cases.3.5. Proﬁle-based clustering
The proﬁle neighbour-joining tree (Fig. 3) shows good
correspondence between cluster membership and known
and/or predicted functions, although much of the deeper
structure of the tree is not supported by bootstrap analysis.
For example, only one known myotoxin lies outside a
cluster containing proteins with similar functions. A
fundamental split between proteins with a mainly hae-
motoxic (and hypotensive) function and proteins having
oedematous, myotoxic or neurotoxic activity is evident.
Apart from the distinct clustering of viperine sequences
(clusters A and B) there is no particularly strong signal of
taxonomy in the tree (e.g., cluster D, which largely groups
toxins from rattlesnakes, also contains toxins from the Old
World genera Ovophis and Gloydius). Interestingly, hypo-
tensive PLA2s seem to be structurally similar in viperines,
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Fig. 2. Discriminant function plot showing A) DF1 against DF2 and B) DF1 against DF4. All functional groups of PLA2 isoforms, except “haemotoxic” and “hy-
potensive”, are successfully discriminated on the ﬁrst two axes while the remaining groups are successfully discriminated on DF4. The intensity of the colour of
the symbol distinguishes proteins with a posterior probability (PP) > 80% of belonging to that group (darker), from those with 50% < PP>80% (paler). Arrows
indicate the position of three isoforms from the venom of Viridovipera stejnegeri, whose bioactivity was investigated in this study.
A. Malhotra et al. / Toxicon 72 (2013) 113–125120occurring in only cluster A, despite disparate speciﬁc ori-
gins. However, in the crotalines, they appear independently
among different clusters, and are always very similar to a
haemotoxic protein. Similarly, oedematous activity and
myotoxicity are also closely related, with whole clusters
being identiﬁed containing proteins known/predicted to
have one of these activities (e.g., clusters C and E, Fig. 3).
The independent evolution of myotoxins is indicated by
their occurrence in each of the two clusters of viperine
PLA2s (A and B) and in several distinct clusters of crotaline
toxins (C, D, E and predicted, but not conﬁrmed, in some
other clusters as well). Although not well illustrated in the
ﬁgure, which shows only one function for each toxin, many
neurotoxins from pitvipers can also display myotoxicity.
This is true of many of the known neurotoxins in cluster C
and D, which may explain many of the discrepancies
observed between known and predicted function in these
clusters. A large number of the inferred haemotoxins
examined, however, are not strongly structurally related
and fall into a number of small clusters whose relationshipsare unclear. Within these are located the small clusters of
PLA2s with known hypotensive activity and, perhaps more
surprisingly, two known neurotoxic PLA2s. These are not
predicted as neurotoxins by DFA, and may have acquired
neurotoxicity recently and independently.
3.6. Comparison with other prediction methods
Results from Protfun 2.2 did not correspond with ex-
pected classiﬁcations. Out of the 49 sequences submitted,
almost half (20) were predicted to be non-enzymes. Of
these, 70% are indeed likely to be PLA2 homologues due to
substitutions present at the critical 49th residue. Overall
the accuracy of predicting enzyme activity was 85.7%, but
none were correctly classed as Hydrolases (EC 3.-.-.-);
instead, six were predicted to be isomerases, and no pre-
dictions were provided for the remainder. EFICAz2.5, on the
other hand, correctly classiﬁed all the sequences tested
as phospholipase A2 enzymes (EC 3.1.1.4) with high conﬁ-
dence, but each protein sequence took nearly two hours to
Fig. 3. A proﬁle neighbour-joining (PNJ) tree of all Group II svPLA2 protein sequences illustrated as a radial cladogram. Branches have been colour coded ac-
cording to the functional predictions derived from the DA, with colours corresponding to those used in Fig. 2. Thick lines represent proteins with a PP >80% of
having that function, while thin lines represent 50% < PP>80%. Black lines indicate proteins which had no clear assignment (PP>50%), or in the case of interior
branches, where descendant sequences had multiple functions. Nodes marked by red circles represent those that are supported by bootstrap values > 50% in the
ﬁnal tree, while those marked by a purple circle represent sequences which have been united into a super-proﬁle by several iterations of PNJ. Peripheral labels
indicate the unique identiﬁer of each protein and the species from which it was identiﬁed. Labels are coloured according to known (experimentally determined)
functions. The outer circle indicates the position of two clades of Viperinae (true viper) sequences, which are clearly distinguished from all other PLA2s of
crotaline (pit viper) origin. Labels A–F identify clusters that are supported by bootstrap values >50% and which are discussed in the text.
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.- (Hydrolases – Acting on Ester Bonds) with 95.9% accu-
racy. For a further two proteins, the classiﬁcation with the
highest probability was “all lipid-binding proteins”. How-
ever, as pointed out earlier, information on enzyme activity
is of limited utility when dealing with multifunctional
proteins such as the svPLA2s. NTXpred tools varied in their
prediction of source, function and speciﬁcity (Table S4) but
all PLA2s tested were predicted to be neurotoxins. In order
to investigate the prediction accuracy further, the amino
acid sequence was randomly mutated and the prediction
tools run after each mutation. At least two out of the 14 Cys
residues that form the crucial backbone of the protein had
to be mutated before the amino-acid þ length tool pre-
dicted a non-toxin, at least four Cys residues had to be
mutated before the dipeptide-based tools failed to predict a
neurotoxin, and all Cys could be mutated and still obtain a
neurotoxin prediction from the “amino-acid sequenceonly” tool. If these cysteine residues were untouched, the
entire remaining amino-acid sequence could be randomly
changed without changing the prediction.
4. Discussion
The prediction of function from protein sequence in the
toxic PLA2s is especially challenging, yielding few insights
despite decades of work in this ﬁeld. To some extent, this
lack of progress can be attributed to incomplete analysis
and lack of standardisation in the toxinological literature.
For example, while reported activities of phospholipases
are very varied (Doley et al., 2009), few have been exten-
sively studied and individual toxins are rarely tested for all
possible activities. Thus, it cannot be ascertained whether
the toxin also shows activities additional to the experi-
mentally demonstrated ones, which may account for some
apparent misclassiﬁcations in predictive methods such as
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considerably and some are far more sensitive than others.
For example, measuring the resting membrane potential in
the mouse phrenic nerve-diaphragm preparation was
found to be around 100-fold more sensitive than the
commonly-used creatine kinase release assay for studying
myotoxicity (Aragão et al., 2009). In addition, the same
pharmacological effect can be induced through different
pathways (Miyabara et al., 2006; Moreira et al., 2008; Zhou
et al., 2008).
Although several attempts have been made to provide a
predictive framework for PLA2 toxins, none of these have
gained widespread use and published databases and
servers eventually become unavailable and/or outdated. As
we have illustrated, a number of more general methods
(not designed speciﬁcally for toxins) lack predictive power,
while speciﬁc tests to identify toxins (Saha and Raghava,
2007) fail to distinguish between different toxic func-
tions. Among the methods not currently accessible, some
reported success in prediction of myotoxic, presynaptic
neurotoxic and anticoagulant functions was achieved by
examining subsets of highly similar toxins (found by
sequence similarity searches of databases) (Chioato and
Ward, 2003). However, the assumption that sequences
with high similarity share a similar function has been
shown to be ﬂawed in this study, wherewe ﬁnd that similarFig. 4. Molecular models showing conserved regions (excluding catalytic and calciu
Top left: clade C (mostly myoxins but with some predicted oedematous and some kn
F (mostly anticoagulant), bottom right: clade D (mostly neurotoxic but also showing
all oriented with beta-sheet on the extreme left (front), the n-terminal helix toward
comparison. Surfaces and residue labels are shown for highly conserved and expose
(Ashkenazy et al., 2010; Landau et al., 2005) using the reported PDB structures of 3I
1PP2 (Crotalus atrox) respectively. The darkest maroon colours are the most conserv
the sample size was too small for a conﬁdent prediction to be made at that site. T
2004). It suggests that each clade has largely non-overlapping active sites.functions may have evolved independently in structurally
different sequences, while some novel functions have
arisen among clusters of highly similar sequence, making it
difﬁcult to identify functional relationships among se-
quences grouped by similarity alone. This is illustrated by
clusters C and D in Figs. 3 and 4, both containing largely
myotoxic/oedematous PLA2s as well as a number of
neurotoxic PLA2s. However, this underlying similarity in
physiological effect is clearly achieved through different
biochemical pathways, as PLA2s in cluster D are all highly
catalytically active, and the neurotoxicity is achieved
through dimerisation with a non-toxic chaperone protein.
Members of cluster C, on the other hand, all havemutations
that have abolished or considerably reduced the catalytic
activity, and when neurotoxic, can express this activity in
the monomeric form. The presence of both these activities
in both these structurally distinct clusters may be one
reason that considerable overlap was found in the surface
residues implicated in myotoxicity and neurotoxicity
(Chioato and Ward, 2003). The paucity of existing data on
some particular functions (e.g., hypotensive PLA2s, where
we were only able to ﬁnd experimental evidence for this
activity for seven isoforms among all viperids) also chal-
lenges the ability of any method to classify them.
Aparticularlyencouraging featureof the current analysis
is the good agreement between cluster membership in them binding sites) in crotaline svPLA2 clades C, D, E and F (as deﬁned in Fig. 3).
own neurotoxins); top right: clade E (mostly oedematous); Bottom left: clade
myotoxic activity, non-toxic without chaperone molecule). The molecules are
s the left (behind), and the c-terminal loop on the extreme right, for ease of
d residues only. Conservation scores were calculated using the ConSurf server
03 (Bothrops jararacussu), 1VIP (Daboia russelii), 2QOG (Crotalus durissus), and
ed while the darkest blue colours are the most variable. Yellow indicates that
he images were produced using the USCF Chimera package (Pettersen et al.,
A. Malhotra et al. / Toxicon 72 (2013) 113–125 123PNJ trees, based on sequence proﬁles, and the functional
predictions from the DFA based on physico-chemical prop-
erties,whichhavedifferent underlyingbases.We also found
good internal consistency between our predictions and
in vitro tests of activity. For example, venom from specimen
T208 (V. stejnegeri from Taiwan) is known from the proteo-
mic analysis to contain major PLA2s that match the MW of
sequenced isoforms A241_9 and B344_LT2. The third major
isoform present matches the MW of Q6H3D4, which was
tested as part of this study and showed no distinct activity.
This matches the prediction from the DFA which could not
clearly assign it to any functional cluster. The crude venom
showed haemorrhagic, oedematous and myotoxic activity.
A241_9 is predicted with a PP of 0.99 to be a haemotoxin
while B344_LT2 is predicted (PP ¼ 0.66) to be a myotoxin,
thus the demonstrated activity of the whole venom is
entirely consistent with the predictions of the functional
activity of its main constituent PLA2s. Similarly, the activity
of the crude venom fromB469, B475, B526, B5, B33 and B67
is entirely consistent with the predicted activity of at least
some of themajor PLA2 toxins that theycontain. The activity
of the venom from B8 (Cryptelytrops insularis) is partly
consistent, in that it is known to contain isoforms that have
predicted activities that are not shown by thewhole venom.
However, in this case, the only major toxin (matching
B5_set2 in MW) is predicted to be haemotoxic (PP ¼ 0.94),
which matches the activity of the crude venom, while the
isoform matching A229_LT5 (with predicted myotoxic ac-
tivity) is only a minor constituent of the venom (data from
the LC–ES–MS). Amore inexplicable inconsistency between
predictedanddemonstrated functions is found in the caseof
the crude venom of A229 (Cryptelytrops albolabris), which
showed only slight haemorrhagic activity and no other ac-
tivity. From the LC–ES–MSproﬁle, we know that this venom
contains seven major isoforms of PLA2, six of which have
been identiﬁed in this study (these are A229_LT5,
A229_LT11, A241_28, B464_LT11, B480_UP, and B769_gpB),
and another which remains unidentiﬁed. Of these,
A229_LT11, A241_28 and B769_gpB have predicted hae-
motoxic activity (PP > 0.9), but B464_LT11 has predicted
neurotoxic activity (PP ¼ 0.82) and A229_LT5 has predicted
myotoxic activity (PP¼0.6). Theremaybe synergistic effects
among this complex cocktail of similar toxins that masks
someof these activities in the crude venom. Thismayalso be
the reason for a dramatic inconsistency between the results
of the functional assays on whole venom and the isolated
toxins in the case of D31778, which was isolated from the
venom of T221 (V. stejnegeri). The isolated toxin shows very
high neurotoxic activity which exceeded that of the positive
control used, yet thewhole venomshowsno such activity. In
this case, the neurotoxicity of D31778 also fails to be pre-
dicted by the DFA (which in fact predicts it to be a haemo-
toxin with very high probability), and in the PNJ tree, is
clustered among other isoforms similarly predicted to be
haemotoxins. It is therefore extremely interesting that
another isoform from V. stejnegeri (P81478) has been inde-
pendently demonstrated to be neurotoxic (Fukagawa et al.,
1993), yet also fails to be predicted as such by the current
methods. This suggests that the another use of the approach
outlined here may be to highlight discrepancies betweenexpected and actual functionswhich, by departing from the
norm,may yield unique information about the gain and loss
of major functions in these versatile proteins.
In conclusion, our study highlights the importance of
considering biological meaningful features of proteins for
detailed understanding of their biological activities. With
the number of venomous animals running intomany tens of
thousands, the search for bioactive compounds as leads in
thepharmaceutical industry in these venomswill need tobe
organised for maximum efﬁciency. A method of providing
an initial hypothesis of function of a novel product that is
capable of highlighting the independent acquisition of
similar functions by toxins of different sequence, that may
act through different pathways, could be a valuable tool in
choosing such lead compounds for further investigation.
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